Clinical Trial Update: Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of Pimecrolimus Cream 1% for atopic dermatitis was terminated with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus Cream 1% (pimecrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 4 | Status: TERMINATED | Results posted: 2011-03-23